Renovaro Biosciences Inc. (NASDAQ: RENB) Stock Information | RedChip

Renovaro Biosciences Inc. (NASDAQ: RENB)


$0.5225
+0.0110 ( +2.15% ) 9.7K

Renovaro Inc is a biopharmaceutical company. It is engaged in the research and development of pharmaceutical and biological products for the treatment of cancer, HIV, and HBV with the intent to manufacture said products.

Market Data


Open


$0.5225

Previous close


$0.5115

Volume


9.7K

Market cap


$79.89M

Day range


$0.4960 - $0.5390

52 week range


$0.3950 - $5.2500

SEC Filings


Form Type Description Pages Date
8-k 8K-related 13 Sep 17, 2024
8-k 8K-related 13 Sep 11, 2024
4 Insider transactions 1 Aug 27, 2024
10-q/a Quarterly Reports 77 Aug 20, 2024
8-k 8K-related 13 Aug 19, 2024
4/a Other 1 Aug 16, 2024
4 Insider transactions 1 Aug 13, 2024
4 Insider transactions 1 Jul 19, 2024
4/a Other 1 Jul 19, 2024
4/a Other 1 Jul 19, 2024

Latest News